|
Patient Safety/ Medical Error
Citations 1-10 of 123 total displayed.
|
Most recent content
(23 Apr 2008):
|
- Commentaries
FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors
- Bruce M. Psaty; Wayne Ray
JAMA 2008; 299: 1949-1951.
[Extract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- Medical News & Perspectives
FDA to Boost Its Presence in China
- Bridget M. Kuehn
JAMA 2008; 299: 1762.
[Extract]
[Full text]
[PDF]
- Original Contributions
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
- MEND-CABG II Investigators*
JAMA 2008; 299: 1777-1787.
[Abstract]
[Full text]
[PDF]
- Special Communications
Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation
- Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 299: 1813-1817.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ]
- Commentaries
When Should Data and Safety Monitoring Committees Share Interim Results in Cardiovascular Trials?
- Jeffrey S. Borer; David J. Gordon; Nancy L. Geller
JAMA 2008; 299: 1710-1712.
[Extract]
[Full text]
[PDF]
- Commentaries
Newly Approved Does Not Always Mean New and Improved
- Geoffrey M. Anderson; David Juurlink; Allan S. Detsky
JAMA 2008; 299: 1598-1600.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Botox Risks Under Review
- Bridget M. Kuehn
JAMA 2008; 299: 1417-c.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Heparin Problem
- Bridget M. Kuehn
JAMA 2008; 299: 1417.
[Extract]
[Full text]
[PDF]
- Commentaries
Surrogate End Points and FDA Approval: A Tale of 2 Lipid-Altering Drugs
- Bruce M. Psaty; Thomas Lumley
JAMA 2008; 299: 1474-1476.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Citing Serious Risks, FDA Recommends No Cold and Cough Medicines for Infants
- Bridget M. Kuehn
JAMA 2008; 299: 887-888.
[Extract]
[Full text]
[PDF]
|
|
